News archivo - Page 4 of 18

17 July 2023

VIVEbiotech participates in the XVI Annual Biotechnology Congress

Soledad Baños-Mateos, senior researcher of the Department of Technological Innovation of VIVEbiotech, has participated in the XVI Congreso Anual de Biotecnología (BAC Badajoz 2023)...

11 July 2023

VIVEbiotech contributes to accelerate the development of muscular dystrophies through the European MAGIC project

VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is currently working on more than 40 international...

19 June 2023

VIVEbiotech interview on C&GT manufacturing trends at Drug Discovery World

VIVEbiotech participated in the ISCT, International Society for Cell & Gene Therapy´s (ISCT) Annual Meeting took place three weeks ago in beautiful Paris.

13 June 2023

Gurutz Linazasoro, CEO of VIVEbiotech, participates in the Foro de Biociencia

Gurutz Linazasoro, CEO of VIVEbiotech, will participate tomorrow in a round table discussion entitled "Boosting science and research of high quality and impact" at the...

4 June 2023

VIVEbiotech has successfully participated in 5 international congresses in the first half of the year

VIVEbiotech has successfully participated in 5 international congresses in the first half of the year.

18 May 2023

Article in RegMedNet about lentiviral vectors development and manufacturing challenges

Natalia Elizalde was interviewed at the Phacilitate's Advanced Therapies Week that took place in Miami in January this year.

18 May 2023

VIVEbiotech collaborates with Gyros Protein Technologies in two Gyrolab Technology Seminars

Bárbara Rodríguez-Urretavizcaya, Analytical Development Scientist, has presented at two Gyrolab Technology Seminars.

10 March 2023

Video-interview by The Medicine Maker

Natalia Elizalde was video-interviewed by The Medicine Maker during Phacilitate´s Advanced Therapies Week that took place in Miami in January.

2 March 2023

Scrip reports on the predictions of VIVEbiotech

Natalia Elizalde has been included in the clinical trial section about the leading annual article series by Scrip alongside a number of leading international figures...

17 February 2023

Gurutz Linazasoro, CEO of VIVEbiotech, participates at Transfiere

Gurutz Linazasoro, CEO of VIVEbiotech and coordinator of the AseBio´s, the Spanish Bioindustry Association ´s, advanced therapies working group, participated yesterday in a round...